Press Releases

NASDAQ: CORV   TSX: CORV VANCOUVER, Sept. 12, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today highlighted that the U.S. Food and Drug Administration (FDA) has accepted for review United Therapeutics Corporation's (NASDAQ: UTHR) New Drug Appl

TORONTO and HOUSTON, Sept. 12, 2019 /PRNewswire/ - Medicenna Therapeutics Corp.  ("Medicenna" or "the Company") (TSX: MDNA, OTCQB: MDNAF), a clinical stage immuno-oncology company, today announced that it will present updated clinical results from the Phase 2b clinical trial of MDNA55 for

Feedback from retailers confirms premium organic segment highly in demand Price premium not a barrier for cannabis consumers looking for high-quality TGOD's high-THC strain, Unite Organic, performing well in premium segment with positive consumer feedback Company already received second order from the OCS as some retailers quickly sold out

VANCOUVER, Sept. 12, 2019 /PRNewswire/ - Choom™ (CSE: CHOO; OTCQB: CHOOF), an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, is pleased to announce that an Alberta provincially approved cannabis retail licensee ("Licensee") is opening

ANNAPOLIS, Md., Sept. 12, 2019 /PRNewswire/ -- Vision Innovation Partners is pleased to announce its acquisition of Washington Eye Specialists, a leading ophthalmology practice located in Washington, D.C. The acquisition further expands Vision Innovation Partners' growing network of ophthalmology practices in the Mid-Atlantic region.

MIAMI, Sept. 12, 2019 /PRNewswire/ -- ArisGlobal today announced details of its annual Life Sciences Technology Summit (AGLSTS 2019), taking place October 1st - 3rd at the Miami Beach EDITION hotel in Miami Beach, Florida. T

SCOTTSDALE, Ariz., Sept. 12, 2019 /PRNewswire/ -- Imaging Endpoints (IE) has announced the opening of its new corporate headquarters in Scottsdale, Arizona to accommodate the company's tremendous growth. The company also has an office in Waltham, Massachusetts as well as staff in

SHANGHAI and GAITHERSBURG, Md., Sept. 12, 2019 /PRNewswire/ -- I-Mab Biopharma (I-Mab), a China and U.S.-based clinical stage biopharmaceutical company exclusively focused on the discovery and development of innovative biologics in immuno-oncology and autoimmune diseases, a

DENVER, Sept. 12, 2019 /PRNewswire/ -- United Cannabis Corporation (OTCQB: CNAB) (the "Company" or "United Cannabis") today announced that it has initiated extraction services at its majority-owned processing plant in McMinnville, Tennessee (the "Facility").

PALO ALTO, Calif., Sept. 12, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that updated data from the clinical development program for its investigational therapy KSI-301 will be presented at The Retina Society Annu